Yingqian Chai

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Joint Research Centre, Center for Translational Molecular Medicine, University of Chinese Academy of Sciences

发表论文 7 篇 · 总被引 135 次 · h-index 5

代表论文

• Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis (2024 · Journal of Nanobiotechnology · 被引 48)
• Engineering Efferocytosis‐Mimicking Nanovesicles to Regulate Joint Anti‐Inflammation and Peripheral Immunosuppression for Rheumatoid Arthritis Therapy (2024 · Advanced Science · 被引 29)
• Chemotactic recruitment of genetically engineered cell membrane-camouflaged metal−organic framework nanoparticles for ischemic osteonecrosis treatment (2024 · Acta Biomaterialia · 被引 18)
• Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy (2024 · Journal of Nanobiotechnology · 被引 18)
• Human Adipose Tissue Lysate‐Based Hydrogel for Lasting Immunomodulation to Effectively Improve Spinal Cord Injury Repair (2023 · Small · 被引 17)
• Efferocytosis-Mimicking Nanovesicle-Cross-Linked Hydrogel for Dual Immunomodulation and Angiogenesis to Prolong Allogeneic Skin Graft Survival (2025 · ACS Nano · 被引 5)